A new study published today in the New England Journal of Medicine found that for young women with hormone receptor-positive breast cancer, pausing endocrine therapy to pursue a pregnancy did not raise the short-term risk that the disease will recur.
Younger Breast Cancer Patients Can Safely Have Baby: Study miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Interrupting endocrine therapy may allow three quarters of women with hormone receptor positive breast cancer to achieve pregnancy, while having no impact on their short-term outcomes, new data suggest.
Breast cancer patients who discontinued endocrine therapy to continue pregnancy did not experience worse short-term recurrence rates miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ GO2 Foundation for Lung Cancer announced today that it will present Dr. Rafael Rosell with the 2022 Bonnie J. Addario Lectureship Award for his.